Browse by multiple fields below
Download csv Download xlsx
This table displays an overview of the database
The table can be sorted by any field, simply by clicking on the column header
The table can be sorted by any field, simply by clicking on the column header
| PDX ID | Sample ID | Patient Id | Sample Site | Sample Source | Age Sample Collected | PSA at diagnosis (ng/mL) | Gleason Score | Primary Gleason Score | Secondary Gleason Score | Grade Group | Tumour Grade | D'Amico Risk Classification | Primary Tumour Volume (cc) | Treatment Prior to Specimen Collection | PDX Host Type | PDX Graft Site | Current PDX Generation | Average PDX Generation Time (days ± SEM) | Tumour preparation2 | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 305R | 305R | 305 | Prostate | Radical prostatectomy | 75-79 | 2 | 9 | 5 | 4 | 5 | pT3bN1 | 7 | 73.4 | None | Testosterone supplemented | Subcutaneous | 26 | 46 ± 2 | Tumor solid | 34413304 |
| 305R Cx | 305R | 305 | Prostate | Radical prostatectomy | 75-79 | 2 | 9 | 5 | 4 | 5 | pT3bN1 | 7 | 73.4 | None | Castrate | Subcutaneous | 45 (22*) | 41 ± 1 | Tumor solid | 34413304 |
| 365R | 365R | 365 | Prostate | Radical prostatectomy | 60-64 | 6.3 | 9 | 4 | 5 | 5 | pT3aN1 | 7 | 8.6 | None | Testosterone supplemented | Renal | 8 | 224 ± 25 | Tumor solid | 34413304 |
| 369R | 369R | 369 | Prostate | Radical prostatectomy | 60-64 | 5.8 | 9 | 4 | 5 | 5 | pT3bN0 | 7 | 13.1 | None | Testosterone supplemented | Subcutaneous | 9 | 105 ± 9 | Tumor solid | 34413304 |
| 386R | 386R | 386 | Prostate | Radical prostatectomy | 70-74 | 6.98 | 9 | 4 | 5 | 5 | pT3bN1 | 7 | 36.0 | None | Testosterone supplemented | Renal | 12 | 135 ± 10 | Tumor solid | 34413304 |
| 167.1R | 167.1R | 167 | Prostate | Radical prostatectomy | 55-59 | 5.2 | 9 | 4 | 5 | 5 | pT3bN0 | 7 | 34.6 | None | Testosterone supplemented | Subcutaneous | 19 | 121 ± 13 | Tumor solid | 34413304; 33620092 |
| 167.2M | 167.2M | 167 | Spine | Surgery | 55-59 | 5.2 | 9 | 4 | 5 | — | — | — | 0.0 | ADT, docetaxel | Testosterone supplemented | Subcutaneous | 27 | 48 ± 2 | Tumor solid | 34413304; 33620092 |
| 167.2M Cx | 167.2M | 167 | Spine | Surgery | 55-59 | 5.2 | 9 | 4 | 5 | — | — | — | 0.0 | ADT, docetaxel | Castrate | Subcutaneous | 29 (12*) | 94 ± 7 | Tumor solid | 34413304; 33620092 |